Atlas Private Wealth Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Atlas Private Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-355	Closed	-$3K	–	630
2021 Q3	$3K	Hold	355	–	–	﹤0.01%	640
2021 Q2	$4K	Hold	355	–	–	﹤0.01%	609
2021 Q1	$4K	Sell	355 -200	-36%	-$2.29K	﹤0.01%	660
2020 Q4	$5K	Sell	555 -200	-26%	-$1.92K	﹤0.01%	538
2020 Q3	$7K	Sell	755 -200	-21%	-$2.12K	0.01%	441
2020 Q2	$12K	Buy	+955	New	+$10.8K	0.01%	386

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Atlas Private Wealth Advisors's TEVA Position: Q4 2021 in Review

Atlas Private Wealth Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2021, closing a stake of 355 shares — an estimated $3K sold.

Atlas Private Wealth Advisors first reported a position in TEVA in Q2 2020 and held it in 6 quarters. The position peaked at $12K in Q2 2020. 450 funds tracked by Wall St. Rank hold TEVA as of Q4 2021.

Atlas Private Wealth Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2021 after selling out during the quarter.
Atlas Private Wealth Advisors sold 355 Teva Pharmaceutical Industries Limited shares in Q4 2021, an estimated $3K.
Atlas Private Wealth Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2020 and held it in 6 quarters.
Atlas Private Wealth Advisors's Teva Pharmaceutical Industries Limited position peaked at $12K in Q2 2020.
450 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2021.

Based on Atlas Private Wealth Advisors's 13F filing for Q4 2021, filed 21 Apr 2022.